• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume10, Issue3

0.5% Lignocaine Versus 0.25% Lignocaine with Opioid+Muscle Relaxant as Adjuvant in Intravenous Regional Anaesthesia: A Randomized Controlled Trial

    Dr Tulika Singh, Dr Gopi Kumhar

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 3, Pages 1299-1304

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Intravenous regional anaesthesia with conventional large dose of local anaesthetic is associated with serious systemic toxicity when the tourniquet deflates unexpectedly during the procedure or when it is deflated intentionally at the  end of surgery. Therefore modifications in IVRA have been done with the use of low dose of local anaesthetic to decrease systemic toxicity and addition of muscle relaxant and opioid to local anaesthetic to get the same quality analgesia as high dose local anaesthetic. Hence the present study is carried out to compare the sensory and motor characteristics, and side-effects during intra- operative and post-operative period between the patients who received 0.5% lignocaine    alone and those who received combination of 40 ml of 0.25% lignocaine with 1 mg butorphanol and 2mg atracurium in intravenous regional anaesthesia for upper limb surgeries  . AIM: 1 .  TO COMPARE THE SENSORY AND MOTOR CHARACTERISTICS IN INTRAVENOUS REGIONAL ANAESTHESIA  IN BOTH THE  GROUPS 2.  TO  COMPARE THE SYSTEMIC SIDE EFFECTS IN THE TWO GROUPS. METHOD: 60 ASA class 1 and 2 patients scheduled for elective upper limb surgeries were randomly allocated to receive IVRA either with 40ml of 0.5% lignocaine alone (Group A, n = 30) or combination of 40 ml of 0.25% lignocaine with 1 mg butorphanol and 2 mg atracurium (Group B, n = 30). The sensory and motor characteristics, cardiovascular & respiratory parameters and side effects were studied during the intra-operative and post-operative period. RESULT: The time of onset of sensory loss & motor block ,the time of complete sensory block, and the time of  complete motor block were significantly delayed in group B.  But the quality of analgesia was similar in both groups after 10-15 minutes of the injection  of  anaesthetic solution. There was no significant difference between two groups in the time of return of full motor power and full sensation There was no significant difference in cardiovascular & respiratory parameters and incidence of side  effects between the two groups. CONCLUSION: The study indicated that the triple combination of 40 ml of 0.25% lignocaine, 1mg butorphanol  and 2mg atracurium produces the same quality of analgesia as 40ml of 0.5% lignocaine in IVRA. Thus, this modified technique of intravenous regional anaesthesia allows a reduction in the dose of local anaesthetic agent thus reducing the potential toxicity of the local anaesthetic agent.
Keywords:
    Intravenous regional anaesthesia Tourniquet lignocaine Butorphanol, Atracurium
  • PDF (326 K)
  • XML
(2023). 0.5% Lignocaine Versus 0.25% Lignocaine with Opioid+Muscle Relaxant as Adjuvant in Intravenous Regional Anaesthesia: A Randomized Controlled Trial. European Journal of Molecular & Clinical Medicine, 10(3), 1299-1304.
Dr Tulika Singh, Dr Gopi Kumhar. "0.5% Lignocaine Versus 0.25% Lignocaine with Opioid+Muscle Relaxant as Adjuvant in Intravenous Regional Anaesthesia: A Randomized Controlled Trial". European Journal of Molecular & Clinical Medicine, 10, 3, 2023, 1299-1304.
(2023). '0.5% Lignocaine Versus 0.25% Lignocaine with Opioid+Muscle Relaxant as Adjuvant in Intravenous Regional Anaesthesia: A Randomized Controlled Trial', European Journal of Molecular & Clinical Medicine, 10(3), pp. 1299-1304.
0.5% Lignocaine Versus 0.25% Lignocaine with Opioid+Muscle Relaxant as Adjuvant in Intravenous Regional Anaesthesia: A Randomized Controlled Trial. European Journal of Molecular & Clinical Medicine, 2023; 10(3): 1299-1304.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 18
  • PDF Download: 17
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus